A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

P Sooriakumaran; P Macanas-Pirard; G Bucca; A Henderson; SE Langley; RW Laing; CP Smith; EE Laing; HM Coley

Back

A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

Journal article

Open access

Peer reviewed

A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

P Sooriakumaran, P Macanas-Pirard, G Bucca, A Henderson, SE Langley, RW Laing, CP Smith, EE Laing and HM Coley

Cancer Genomics Proteomics, Vol.6(2), pp.93-99

03/2009

Abstract

Base Sequence

Cyclooxygenase Inhibitors

DNA Primers

DNA

Complementary

Gene Expression Profiling

Humans

Male

Oligonucleotide Array Sequence Analysis

Polymerase Chain Reaction

Prostatic Neoplasms

Pyrazoles

Single-Blind Method

Sulfonamides

We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.

Files and links (2)

pdf

Sooriakumaran_2009100.91 kBDownload View

TextSRIDA, Open Access

url

http://cgp.iiarjournals.org/content/6/2/93.shortView

Published (Version of record)

Metrics

83 File views/ downloads

38 Record Views

Details

Title: A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
Creators: P Sooriakumaran
P Macanas-Pirard
G Bucca
A Henderson
SE Langley
RW Laing
CP Smith
EE Laing
HM Coley
Publication Details: Cancer Genomics Proteomics, Vol.6(2), pp.93-99
Publisher: International Institute of Anticancer Research (IIAR)
Date published: 03/2009
Date submitted: 06/02/2012
Identifiers: 99515152602346
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article

A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

Abstract

Files and links (2)

Metrics

Details

Usage Policy